Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparative Effectiveness of Commonly Used Systemic Treatments or Phototherapy for Moderate to Severe Plaque Psoriasis in the Clinical Practice Setting
Joel M. Gelfand, Joy Wan, Kristina Callis Duffin, et al.
Archives of Dermatology (2012) Vol. 148, Iss. 4, pp. 487-487
Open Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

Secukinumab long-term safety experience: A pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis
P.C.M. van de Kerkhof, C.E.M. Griffiths, Kristian Reich, et al.
Journal of the American Academy of Dermatology (2016) Vol. 75, Iss. 1, pp. 83-98.e4
Closed Access | Times Cited: 296
Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies
Alan Menter, Joel M. Gelfand, Cody Connor, et al.
Journal of the American Academy of Dermatology (2020) Vol. 82, Iss. 6, pp. 1445-1486
Open Access | Times Cited: 258
Secukinumab shows significant efficacy in palmoplantar psoriasis: Results from GESTURE, a randomized controlled trial
Alice B. Gottlieb, John Sullivan, Martijn B. A. van Doorn, et al.
Journal of the American Academy of Dermatology (2016) Vol. 76, Iss. 1, pp. 70-80
Open Access | Times Cited: 141
Tacrolimus and curcumin co-loaded liposphere gel: Synergistic combination towards management of psoriasis
Anjali Jain, Sindhu Doppalapudi, Abraham J. Domb, et al.
Journal of Controlled Release (2016) Vol. 243, pp. 132-145
Closed Access | Times Cited: 117
Research gaps in psoriasis: Opportunities for future studies
Caitriona Ryan, Neil J. Korman, Joel M. Gelfand, et al.
Journal of the American Academy of Dermatology (2013) Vol. 70, Iss. 1, pp. 146-167
Closed Access | Times Cited: 113
Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis
Howa Yeung, Joy Wan, Abby S. Van Voorhees, et al.
Journal of the American Academy of Dermatology (2012) Vol. 68, Iss. 1, pp. 64-72
Open Access | Times Cited: 113
Palmoplantar psoriasis is associated with greater impairment of health-related quality of life compared with moderate to severe plaque psoriasis
Jina Chung, Kristina Callis Duffin, Junko Takeshita, et al.
Journal of the American Academy of Dermatology (2014) Vol. 71, Iss. 4, pp. 623-632
Open Access | Times Cited: 100
Liposphere mediated topical delivery of thymoquinone in the treatment of psoriasis
Anjali Jain, Venkatesh Pooladanda, Upendra Bulbake, et al.
Nanomedicine Nanotechnology Biology and Medicine (2017) Vol. 13, Iss. 7, pp. 2251-2262
Closed Access | Times Cited: 88
Patient satisfaction with treatments for moderate-to-severe plaque psoriasis in clinical practice
Kristina Callis Duffin, Howa Yeung, Junko Takeshita, et al.
British Journal of Dermatology (2013) Vol. 170, Iss. 3, pp. 672-680
Open Access | Times Cited: 86
Comparative effectiveness of biologic agents for the treatment of psoriasis in a real-world setting: Results from a large, prospective, observational study (Psoriasis Longitudinal Assessment and Registry [PSOLAR])
Bruce Strober, Robert Bissonnette, David Fiorentino, et al.
Journal of the American Academy of Dermatology (2016) Vol. 74, Iss. 5, pp. 851-861.e4
Closed Access | Times Cited: 80
Shrinking the Psoriasis Assessment Gap: Early Gene-Expression Profiling Accurately Predicts Response to Long-Term Treatment
Joel Corrêa da Rosa, Jaehwan Kim, Suyan Tian, et al.
Journal of Investigative Dermatology (2016) Vol. 137, Iss. 2, pp. 305-312
Open Access | Times Cited: 78
Diagnosis and Treatment of Pediatric Psoriasis: Current and Future
Kara N. Shah
American Journal of Clinical Dermatology (2013) Vol. 14, Iss. 3, pp. 195-213
Closed Access | Times Cited: 75
Patient-reported outcomes for psoriasis patients with clear versus almost clear skin in the clinical setting
Junko Takeshita, Kristina Callis Duffin, Daniel B. Shin, et al.
Journal of the American Academy of Dermatology (2014) Vol. 71, Iss. 4, pp. 633-641
Open Access | Times Cited: 74
OBSERVE-5: Observational postmarketing safety surveillance registry of etanercept for the treatment of psoriasis final 5-year results
Alexa B. Kimball, Kenneth J. Rothman, Gregory Kricorian, et al.
Journal of the American Academy of Dermatology (2014) Vol. 72, Iss. 1, pp. 115-122
Open Access | Times Cited: 68
Flexible liposomal gel dual-loaded with all-trans retinoic acid and betamethasone for enhanced therapeutic efficiency of psoriasis
Wei Wang, Gaofeng Shu, Kong-jun Lu, et al.
Journal of Nanobiotechnology (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 55
Breakthroughs and bottlenecks of psoriasis therapy: Emerging trends and advances in lipid based nano-drug delivery platforms for dermal and transdermal drug delivery
Siddharth Singh, Rajendra Awasthi
Journal of Drug Delivery Science and Technology (2023) Vol. 84, pp. 104548-104548
Closed Access | Times Cited: 20
Intentional and Unintentional Medication Non-Adherence in Psoriasis: The Role of Patients’ Medication Beliefs and Habit Strength
Rachael Thorneloe, C.E.M. Griffiths, Richard Emsley, et al.
Journal of Investigative Dermatology (2017) Vol. 138, Iss. 4, pp. 785-794
Open Access | Times Cited: 62
Topical Administration of Dual siRNAs Using Fusogenic Lipid Nanoparticles for Treating Psoriatic-Like Plaques
Srujan Marepally, Cedar H. A. Boakye, Apurva R. Patel, et al.
Nanomedicine (2014) Vol. 9, Iss. 14, pp. 2157-2174
Closed Access | Times Cited: 57
Enhanced transdermal efficiency of curcumin-loaded peptide-modified liposomes for highly effective antipsoriatic therapy
Yu Fan, Yuanyuan Zhang, Yang Chen, et al.
Journal of Materials Chemistry B (2021) Vol. 9, Iss. 24, pp. 4846-4856
Closed Access | Times Cited: 33
HSP90 inhibitor RGRN‐305 for oral treatment of plaque‐type psoriasis: efficacy, safety and biomarker results in an open‐label proof‐of‐concept study*
Anne Bregnhøj, Katrine Kyd Holstein Thuesen, Thomas Emmanuel, et al.
British Journal of Dermatology (2021) Vol. 186, Iss. 5, pp. 861-874
Closed Access | Times Cited: 29
Comparative effectiveness of less commonly used systemic monotherapies and common combination therapies for moderate to severe psoriasis in the clinical setting
Junko Takeshita, Shuwei Wang, Daniel B. Shin, et al.
Journal of the American Academy of Dermatology (2014) Vol. 71, Iss. 6, pp. 1167-1175
Open Access | Times Cited: 38
Serious infections among a large cohort of subjects with systemically treated psoriasis
Allison S. Dobry, Charles P. Quesenberry, G. Thomas Ray, et al.
Journal of the American Academy of Dermatology (2017) Vol. 77, Iss. 5, pp. 838-844
Open Access | Times Cited: 35
Early Quantification of Systemic Inflammatory Proteins Predicts Long-Term Treatment Response to Tofacitinib and Etanercept
Lewis Tomalin, Jaehwan Kim, Joel Corrêa da Rosa, et al.
Journal of Investigative Dermatology (2019) Vol. 140, Iss. 5, pp. 1026-1034
Open Access | Times Cited: 34
Eliciting Preferences to Inform Patient-Centred Policies: the Case of Psoriasis
Aleksandra Torbica, Giovanni Fattore, Fabio Ayala
PharmacoEconomics (2014) Vol. 32, Iss. 2, pp. 209-223
Closed Access | Times Cited: 34
Factors Associated with Drug Survival of Methotrexate and Acitretin in Patients with Psoriasis
Guy Shalom, Devy Zisman, Ilana Harman‐Boehm, et al.
Acta Dermato Venereologica (2015) Vol. 95, Iss. 8, pp. 973-977
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top